Latest filing published 18 Mar 2015 for PTC Therapeutics, INC., €118k.
Insider track record
No signal scores available.
Michael L. Kranda: trading record in brief
Michael L. Kranda appears in our data through filings on PTC Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 14 March 2014 to 16 March 2015, the count stands at 3 filings.
Sales make up the whole of the open-market record (3 sales, €200k). So far in 2015, the count stands at no purchases and 2 sales.
On 18 March 2015 came the latest disclosure, an open-market sale for €118k in PTC Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Michael L. Kranda
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,700 shares@ US$72.61Common StockSEC:0001179110-15-005204:0
- 800 shares@ US$73.25Common StockSEC:0001179110-15-005204:1
- 1,186 shares@ US$31.02Common StockSEC:0001179110-14-005283:0
3 of 3 declarations
